Article Information
- Received April 1, 2011
- Revision received June 4, 2011
- Accepted June 8, 2011
- First published July 27, 2011.
- Version of record published July 27, 2011.
Author Information
Author contributions
Author contributions: S.E. and J.Z. designed research; S.E. and X.Q.S. performed research; S.R. contributed unpublished reagents/analytic tools; S.E., X.Q.S., and J.Z. analyzed data; S.E., S.R., and J.Z. wrote the paper.
Disclosures
- Received April 1, 2011.
- Revision received June 4, 2011.
- Accepted June 8, 2011.
This work was supported by Canadian Institutes for Health Research (CIHR) Grant MOP-77624 (J.Z.), the Fonds de la Recherche en Santé du Québec/Quebec Pain Research Network/Pfizer partnership (J.Z.), The Louise and Alan Edwards Foundation (J.Z.), and The Alan Edwards Center for Research on Pain/AstraZeneca Alliance (J.Z.), and by a Canadian Pain Society Trainee Grant (S.E.). We acknowledge the support from the CIHR Neuroinflammation Training Program. S.E. holds a CIHR doctoral studentship. J.Z. is a CIHR new investigator, and S.R. is a Canadian Research Chair in Neuroimmunology.
- Correspondence should be addressed to Dr. Ji Zhang, The Alan Edwards Centre for Research on Pain, McGill University, 740, Dr. Penfield Avenue, Genome Building, Suite 3200C, Montreal, Quebec H3A 2B2, Canada. ji.zhang{at}mcgill.ca
Online Impact